Among this series, compound St.29 (Table 5) showed a potent inhibitory effect against MDA-MB-231 and MCF-7 breast cancer cell lines with low IC50 values, as well as a selective inhibitory effect against CDK4/6. This evidence concerns the gene CDK4 and breast carcinoma.